Good MorningEquity markets eked out small gains on Wednesday after the CPI report came in as expected. The report shows that consumer-level inflation is cooling in alignment with the outlook for FOMC rate cuts, but not so quickly that it raises the risk of recession. The takeaway is that the US economy is on track for a shift that should reinvigorate activity, but risks remain. Among them is the possibility that lower rates will reinvigorate inflation and keep the FOMC from cutting quickly.
The next major hurdle for the market is today. The combination of retail sales data and Walmart results will give a clear indication of spending habits and help the market assess the recession risks. So long as consumer spending is solid, the US economy is unlikely to experience an economic contraction, although slowing is not out of the question. An environment of lower but still high interest rates and persistent inflation could easily lead to a period of stagflation. Featured: My grim warning about AI stocks (Porter & Company) 
|
Markets | | | Wall Street rallied to one of its best days of the year Thursday after data showed the U.S. economy is holding up better than expected, with particular credit going to the country’s shoppers. The S&P 500 jumped 1.6% for its fourth-best day of the year and its sixth straight gain as the U.S. stoc... Read the Full Story |
|
From Our PartnersOur new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will create the greatest investment opportunity for Americans since WWII. Similar stocks in the past have seen peak gains of 16,270%in just 18 months. | | | | See the details here now. |
|
Markets | | |
Wall Street analysts understand that their reputations and careers are on the line each time they issue a recommendation for—or against—a stock. Knowing this, investors would find the weight of the decision-making and stock rating all the more important now that the S&P 500 has sur... Read the Full Story |
|
Markets | | |
Whether the product of genuine market forces or psychology, the September Effect — the tendency for September to be, on average, the worst month of the year for the market — can have a very real impact. Couple that with mounting fears of a recession, and things get even more uncertain ... Read the Full Story |
|
From Our PartnersIn uncertain times, savvy investors turn to reliable assets. Discover the enduring power of gold with our free guide, "The Conservative Man's Guide to Buying Physical Gold Online." Click below to opt-in. | | | | [Download Your Free Guide Today] |
|
Markets | | |
Brinker International’s (NYSE: EAT) stock price fell 15% following its Q4 release, which presented an appetizing dip for investors to snack on. Weaker-than-expected earnings and softer-than-expected guidance caused the dip, but that is the worst news to be found. The remaining details prov... Read the Full Story |
|
Markets | | |
Serve Robotics (NASDAQ: SERV) is up by double-digits following its Q2 release and may continue increasing because of its operational improvements. However, every positive detail is offset by a negative, raising doubts about the stock price trajectory. The market for SERV remains below a critical... Read the Full Story |
|
From Our PartnersImagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. | | | | >> Dive into the Workshop Here |
|
Markets | | | Japan’s economy grew at an annual rate of 3.1% in the April-June period, rebounding from the contraction in the previous quarter, government data showed Thursday. The world’s fourth largest economy grew 0.8% in the fiscal first quarter, according to the Cabinet Office.Seasonally adjusted gross domes... Read the Full Story |
|
Markets | | | Warren Buffett offered more details Wednesday about the stocks he has been selling lately, including confirming that he sold more than 389 million Apple shares during the second quarter.Berkshire Hathaway still owns 400 million shares of the iPhone maker, so it remains the biggest position in the co... Read the Full Story |
|
Stocks | | | More sunshine could be in the forecast for solar power companies like SolarEdge Technologies and Sunrun, whose stock prices have been dimmed by high interest rates.Wall Street is betting that those high rates could start coming down by September. The Fed's key rate is at a two-decade high, making bo... Read the Full Story |
|
Markets | | | Dubai-based port operator DP World has reported its half-year profits fell by nearly 60%, in part over the ongoing attacks by Yemen’s Houthi rebels over the Israel-Hamas war that have affected shipping through the Red Sea Read the Full Story |
|
Markets | | |
Canopy Growth (NASDAQ: CGC) is one of the North American players in the cannabis industry. The company’s shares have seen massive fluctuations since going public in 2014 under the name Tweed Incorporated. The company's value reached nearly $20 billion in early 2021 but now sits at just $57... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York. | | View Today's Stock Pick |
|
